SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
193 hedge funds and large institutions have $571M invested in SANGAMO THERAPEUTICS INC in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 28 closing their positions.
48% more call options, than puts
Call options by funds: $7.57M | Put options by funds: $5.1M
7% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 28
1% more ownership
Funds ownership: 51.79% → 52.79% (+1%)
0% more funds holding
Funds holding: 193 → 193 (0)
0% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 59
16% less capital invested
Capital invested by funds: $679M → $571M (-$107M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$9.59M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$7.94M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.45M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.14M |
| 5 |
BlackRock
New York
|
+$3.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$5.47M |
| 2 |
JP Morgan Chase
New York
|
-$3.77M |
| 3 |
Goldman Sachs
New York
|
-$3.71M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.14M |
| 5 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$2.06M |
SGMO Hedge Fund Activity: Q4 2021 in Review
193 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2021, worth a combined $571M — down 16% from $679M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new SGMO positions and 28 closed out — a net gain of 2 holders — while 59 added to existing stakes and 59 trimmed.
The largest buyer was Millennium Management, adding an estimated $9.59M. The largest seller was SG Americas Securities, cutting an estimated $5.47M.
- 193 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $571M of SANGAMO THERAPEUTICS INC stock for Q4 2021, down 16% quarter-over-quarter.
- 30 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2021 and 28 closed out, a net change of +2 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2021 was Millennium Management, an estimated $9.59M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2021 was SG Americas Securities, an estimated $5.47M sold.
Based on aggregated 13F filings for Q4 2021.